Epidermal growth factor receptor levels are reduced in mice with targeted disruption of the protein kinase A catalytic subunit

BACKGROUND: Epidermal Growth Factor Receptor (EGFR) is a key target molecule in current treatment of several neoplastic diseases. Hence, in order to develop and improve current drugs targeting EGFR signalling, an accurate understanding of how this signalling pathway is regulated is required. It has...

Descripción completa

Detalles Bibliográficos
Autores principales: Oksvold, Morten P, Funderud, Ane, Kvissel, Anne-Katrine, Skarpen, Ellen, Henanger, Heidi, Huitfeldt, Henrik S, Skålhegg, Bjørn S, Ørstavik, Sigurd
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2324083/
https://www.ncbi.nlm.nih.gov/pubmed/18380891
http://dx.doi.org/10.1186/1471-2121-9-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2324083/
https://www.ncbi.nlm.nih.gov/pubmed/18380891
http://dx.doi.org/10.1186/1471-2121-9-16

Ejemplares similares